Metropolitan Life Insurance Company (MetLife)’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-660
| Closed | -$32K | – | 2015 |
|
|
2024
Q1 | $32K | Hold |
660
| – | – | ﹤0.01% | 1634 |
|
|
2023
Q4 | $35.4K | Hold |
660
| – | – | ﹤0.01% | 1626 |
|
|
2023
Q3 | $38.7K | Hold |
660
| – | – | ﹤0.01% | 1544 |
|
|
2023
Q2 | $41.6K | Hold |
660
| – | – | ﹤0.01% | 1530 |
|
|
2023
Q1 | $41.5K | Hold |
660
| – | – | ﹤0.01% | 1496 |
|
|
2022
Q4 | $35.1K | Hold |
660
| – | – | ﹤0.01% | 1696 |
|
|
2022
Q3 | $37K | Hold |
660
| – | – | ﹤0.01% | 1658 |
|
|
2022
Q2 | $47.8K | Sell |
660
-150
| -19% | -$11.2K | ﹤0.01% | 1540 |
|
|
2022
Q1 | $64.4K | Sell |
810
-2,561
| -76% | -$231K | ﹤0.01% | 1451 |
|
|
2021
Q4 | $341K | Hold |
3,371
| – | – | ﹤0.01% | 1666 |
|
|
2021
Q3 | $311K | Hold |
3,371
| – | – | ﹤0.01% | 1747 |
|
|
2021
Q2 | $345K | Buy |
3,371
+149
| +5% | +$15K | ﹤0.01% | 1761 |
|
|
2021
Q1 | $314K | Hold |
3,222
| – | – | ﹤0.01% | 1721 |
|
|
2020
Q4 | $248K | Hold |
3,222
| – | – | ﹤0.01% | 1795 |
|
|
2020
Q3 | $237K | Sell |
3,222
-742
| -19% | -$59.5K | ﹤0.01% | 1672 |
|
|
2020
Q2 | $291K | Hold |
3,964
| – | – | 0.01% | 1565 |
|
|
2020
Q1 | $229K | Hold |
3,964
| – | – | ﹤0.01% | 1517 |
|
|
2019
Q4 | $311K | Sell |
3,964
-912
| -19% | -$67.2K | 0.01% | 1618 |
|
|
2019
Q3 | $333K | Buy |
4,876
+814
| +20% | +$54.7K | 0.01% | 1538 |
|
|
2019
Q2 | $323K | Hold |
4,062
| – | – | 0.01% | 1573 |
|
|
2019
Q1 | $341K | Hold |
4,062
| – | – | 0.01% | 1547 |
|
|
2018
Q4 | $478K | Sell |
4,062
-420
| -9% | -$48.6K | 0.01% | 1212 |
|
|
2018
Q3 | $540K | Hold |
4,482
| – | – | 0.01% | 1306 |
|
|
2018
Q2 | $517K | Buy |
4,482
+623
| +16% | +$68.2K | 0.01% | 1290 |
|
|
2018
Q1 | $331K | Buy |
3,859
+167
| +5% | +$12.9K | ﹤0.01% | 1543 |
|
|
2017
Q4 | $273K | Sell |
3,692
-4,378
| -54% | -$293K | ﹤0.01% | 1699 |
|
|
2017
Q3 | $466K | Hold |
8,070
| – | – | ﹤0.01% | 1735 |
|
|
2017
Q2 | $517K | Hold |
8,070
| – | – | ﹤0.01% | 1665 |
|
|
2017
Q1 | $465K | Hold |
8,070
| – | – | ﹤0.01% | 1695 |
|
|
2016
Q4 | $494K | Hold |
8,070
| – | – | ﹤0.01% | 1736 |
|
|
2016
Q3 | $558K | Hold |
8,070
| – | – | ﹤0.01% | 1640 |
|
|
2016
Q2 | $450K | Hold |
8,070
| – | – | ﹤0.01% | 1764 |
|
|
2016
Q1 | $490K | Hold |
8,070
| – | – | ﹤0.01% | 1585 |
|
|
2015
Q4 | $515K | Hold |
8,070
| – | – | ﹤0.01% | 1608 |
|
|
2015
Q3 | $541K | Sell |
8,070
-380
| -4% | -$26.9K | ﹤0.01% | 1586 |
|
|
2015
Q2 | $577K | Sell |
8,450
-514
| -6% | -$32.6K | ﹤0.01% | 1649 |
|
|
2015
Q1 | $498K | Hold |
8,964
| – | – | ﹤0.01% | 1562 |
|
|
2014
Q4 | $460K | Hold |
8,964
| – | – | ﹤0.01% | 1813 |
|
|
2014
Q3 | $330K | Hold |
8,964
| – | – | ﹤0.01% | 2005 |
|
|
2014
Q2 | $350K | Sell |
8,964
-202
| -2% | -$7.5K | ﹤0.01% | 2084 |
|
|
2014
Q1 | $345K | Buy |
9,166
+22
| +0.2% | +$768 | ﹤0.01% | 2060 |
|
|
2013
Q4 | $346K | Hold |
9,144
| – | – | ﹤0.01% | 2076 |
|
|
2013
Q3 | $397K | Buy |
9,144
+110
| +1% | +$4.42K | ﹤0.01% | 1917 |
|
|
2013
Q2 | $327K | Buy |
+9,034
| New | +$275K | ﹤0.01% | 1991 |
|
Other funds holding USNA
Metropolitan Life Insurance Company (MetLife)'s USNA Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Usana Health Sciences (USNA) in Q2 2024, closing a stake of 660 shares — an estimated $32K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in USNA in Q2 2013 and held it in 44 quarters. The position peaked at $577K in Q2 2015. 154 funds tracked by Wall St. Rank hold USNA as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Usana Health Sciences position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 660 Usana Health Sciences shares in Q2 2024, an estimated $32K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Usana Health Sciences in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Usana Health Sciences position peaked at $577K in Q2 2015.
- 154 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.